Form 4: TELA Bio CEO Antony Koblish Reports Stock Transactions
SEC Form 4 Filing
CEO of TELA Bio, Antony Koblish, reports acquisition and disposal of company stock and stock options.
Summary
- Antony Koblish, CEO of TELA Bio, filed a Form 4 detailing changes in beneficial ownership.
- On February 21, 2025, Koblish acquired 149,000 shares of common stock.
- Also on February 21, 2025, Koblish acquired 219,000 stock options with an exercise price of $2.72, expiring on February 21, 2035.
- On February 23 and 24, 2025, Koblish disposed of 11,631 and 5,772 shares of common stock respectively to cover withholding taxes.
- Following these transactions, Koblish directly owns 590,494 shares of common stock and 219,000 stock options.
Sentiment
Score: 6
Explanation: Neutral sentiment. The filing primarily reflects routine stock transactions related to executive compensation and tax obligations. The acquisition of shares and options is mildly positive, while the disposal for tax purposes is neutral.
Positives
- The acquisition of 149,000 shares by the CEO could be interpreted as a positive signal, indicating confidence in the company's future prospects.
- The grant of 219,000 stock options aligns the CEO's interests with those of the shareholders, incentivizing him to increase the company's value.
Negatives
- The disposal of 17,403 shares to cover withholding taxes, while routine, slightly reduces the CEO's direct ownership.
Future Outlook
The restricted stock units will vest in four equal annual installments beginning on February 21, 2026, subject to the Reporting Person's continuous service through the applicable vesting dates. The option vests 25% on February 21, 2026, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. Investors often monitor these filings to gauge management's sentiment and confidence in the company's prospects.
Stakeholder Impact
- The transactions may have a minor impact on shareholder sentiment, depending on how investors interpret the CEO's trading activity.
Key Dates
| Date | Description |
|---|---|
| 02/21/2025 | Acquisition of 149,000 common stock shares and 219,000 stock options. |
| 02/23/2025 | Disposal of 11,631 common stock shares for tax withholding. |
| 02/24/2025 | Disposal of 5,772 common stock shares for tax withholding. |
| 02/25/2025 | Date of Form 4 filing. |
| 02/21/2026 | First vesting date for 25% of the stock options. |
| 02/21/2035 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.